| (210) | Number of the EPO application | 17764092 |
| (220) | Filing date of the EPO application | 2017.03.09 |
| (80) | EPO patent specification publication (B) | EPB nr. 16/2022, 2022.04.20 |
| (110) | EPO patent number | 3426251 |
| (11) | Number of the document | MD 3426251 T2 |
| (21) | Number of the application | e 2019 0089 |
| (71) | Name(s) of applicant(s), code of the country | JANSSEN PHARMACEUTICA NV, BE; |
| (72) | Name(s) of inventor(s), code of the country | KENT Justine M., US;
DREVETS Wayne C., US;
DE BOER Peter, BE; |
| (73) | Name(s) of owner(s), code of the country | JANSSEN PHARMACEUTICA NV, BE; |
| (54) | Title of the invention | Methods of treating depression using orexin-2 receptor antagonists |
| (13) | Kind-of-document code | T2 |
| (51) | International Patent Classification | A61K 45/06 (2006.01.01); A61K 9/00 (2006.01.01); A61K 9/10 (2006.01.01); A61K 47/38 (2006.01.01); A61K 9/20 (2006.01.01); A61K 31/506 (2006.01.01) |
| (19) | Country | BE |
| (41) | Date of publication of the application | 2019.02.28 |
| (49) | Date of publication of the translation of the validated European patent specification | 2022.09.30 |
| (30) | Priority | 201662306487 P, 2016.03.10, US |
| (74) | Patent attorney | (Procedură) PARASCA Dumitru, str. Eminescu nr. 40, ap. 13, c/p 28, MD-2012, Chişinău, Republica Moldova |
| (86) | International application | PCT/US2017/021565, 2017.03.09 |
| (87) | International publication | WO 2017/156266, 2017.09.14 |